N. C. Tebbutt

Location of colon cancer (right-sided versus left-sided) as a prognostic factor and a predictor of benefit from cetuximab in NCIC CO.17.

C. Underhill, S. Brule, C. O'Callaghan, 2015, European journal of cancer.

Hope, optimism and survival in a randomised trial of chemotherapy for metastatic colorectal cancer

M. Stockler, N. Pavlakis, R. Simes, 2015, Supportive Care in Cancer.

A phase I trial of imatinib in combination with mFOLFOX6–bevacizumab in patients with advanced colorectal cancer

P. Gibbs, L. Lipton, J. Zalcberg, 2013, Cancer Chemotherapy and Pharmacology.

Using bevacizumab with different chemotherapeutic regimens in metastatic colorectal cancer: balancing utility with low toxicity

N. Tebbutt, G. Chong, Niall C. Tebbutt, 2010, Therapeutic advances in medical oncology.

Capecitabine, bevacizumab, and mitomycin in first-line treatment of metastatic colorectal cancer: results of the Australasian Gastrointestinal Trials Group Randomized Phase III MAX Study.

M. Stockler, V. Gebski, R. Simes, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Randomised, non-comparative phase II study of weekly docetaxel with cisplatin and 5-fluorouracil or with capecitabine in oesophagogastric cancer: the AGITG ATTAX trial

M. Stockler, V. Gebski, J. Zalcberg, 2010, British Journal of Cancer.

Single-agent irinotecan or FOLFIRI as second-line chemotherapy for advanced colorectal cancer; results of a randomised phase II study (DaVINCI) and meta-analysis [corrected].

V. Gebski, D. Goldstein, J. Zalcberg, 2011, European journal of cancer.

Preoperative chemoradiotherapy and postoperative chemotherapy with capecitabine and oxaliplatin versus capecitabine alone in locally advanced rectal cancer: First results of the PETACC-6 randomized phase III trial

K. Haustermans, B. Nordlinger, M. Mauer, 2013 .

TACTIC: a multicentre, open-label, single-arm phase II trial of panitumumab, cisplatin, and gemcitabine in biliary tract cancer

V. Gebski, D. Goldstein, J. Zalcberg, 2016, Cancer Chemotherapy and Pharmacology.